{
  "url": "https://openlegislation.uk/medicines-for-human-use-miscellaneous-amendments-no2-regulations-2009/regulation-3",
  "json_url": "https://openlegislation.uk/medicines-for-human-use-miscellaneous-amendments-no2-regulations-2009/regulation-3.json",
  "legislation": "uksi/2009/3063",
  "legislation_title": "The Medicines for Human Use (Miscellaneous Amendments) (No.2) Regulations 2009",
  "legislation_url": "https://openlegislation.uk/medicines-for-human-use-miscellaneous-amendments-no2-regulations-2009",
  "path": "regulation/3",
  "kind": "regulation",
  "number": "3",
  "heading": "Amendment of the Sale or Supply Regulations",
  "text": "(1) The Sale or Supply Regulations shall be amended as follows.\n(2) In regulation 1(2) (citation, commencement and interpretation), after the definition of “community practitioner nurse prescriber” insert—\n““contact lens specialist” means a person who is a registered dispensing optician and against whose name particulars of the contact lens speciality have been entered in the register of dispensing opticians maintained under section 7(b) of the Opticians Act 1989;”;\n““registered dispensing optician” means a person registered in the register of dispensing opticians maintained under section 7(b) of the Opticians Act 1989;”.\n(3) In regulation 5 (restrictions on persons to be supplied with certain medicinal products) at the end insert—\n“(g) to a registered dispensing optician (“D”), prescription only medicines which—\n(i) are required for use by registered optometrists and doctors attending D’s practice but only if the medicine contains any one or more of the following substances—\nAmethocaine hydrochloride,\nChloramphenicol,\nCyclopentolate hydrochloride,\nFusidic acid,\nLignocaine hydrochloride,\nOxybuprocaine hydrochloride,\nProxymetacaine hydrochloride,\nTropicamide;\n(ii) are required for use by D in the course of D’s professional practice as a contact lens specialist but only if the medicine contains any one or more of the following substances—\nLignocaine hydrochloride,\nOxybuprocaine hydrochloride,\nProxymetacaine hydrochloride.”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "1989 c.44; section 7 was amended by S.I. 2005/848, articles 2 and 7(1)(a) and (b)."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2009/3063/regulation/3",
    "retrieved_at": "2026-10-29T03:01:08.007118+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}